Ciro Spedaliere

Prepare for Meeting →

Managing Partner

Claris Ventures

Check size: Claris Ventures does not publish a standard check-size range on its current official site.

Investment Thesis

Ciro Spedaliere invests or supports investment decisions through Claris Ventures's published strategy: Build and invest in biopharma companies arising from the Italian research ecosystem around transformational therapies for major unmet patient needs.

What Excites Them

Exceptional science, strong translational potential, credible intellectual property and teams capable of developing transformational medicines.

What They Pass On

Projects outside therapeutics and biopharma, or without strong scientific evidence and Italian ecosystem relevance, are less aligned.

How to Pitch

Show the unmet need, mechanism and evidence, IP position, development plan, founding scientific team and milestones to the next value inflection.

Notable Writing

No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.

Podcast Appearances

No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.

Key Quotes

Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.

Background

Ciro Spedaliere is a current Managing Partner at Claris Ventures, according to the firm's official roster. No education, prior employment or personal deal claims are inferred where the firm does not publish them.

Share
Requests are processed by our agent pipeline nightlyIs this you? Request removal